Assessment of the Antibacterial Efficacy of Halicin against Pathogenic Bacteria
Artificial intelligence (AI) is a new technology that has been employed to screen and discover new drugs. Using AI, an anti-diabetic treatment (Halicin) was nominated and proven to have a unique antibacterial activity against several harmful bacterial strains, including multidrug-resistant bacteria....
Saved in:
Main Authors: | Rayan Y. Booq (Author), Essam A. Tawfik (Author), Haya A. Alfassam (Author), Ahmed J. Alfahad (Author), Essam J. Alyamani (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Delivery of the Novel Drug 'Halicin' Using Electrospun Fibers for the Treatment of Pressure Ulcer against Pathogenic Bacteria
by: Walaa S. Aburayan, et al.
Published: (2020) -
Halicin: A New Horizon in Antibacterial Therapy against Veterinary Pathogens
by: Shuge Wang, et al.
Published: (2024) -
Novel Antibacterial Agents SAAP-148 and Halicin Combat Gram-Negative Bacteria Colonizing Catheters
by: Nesrine Bouhrour, et al.
Published: (2023) -
Synergism between the Synthetic Antibacterial and Antibiofilm Peptide (SAAP)-148 and Halicin
by: Miriam E. van Gent, et al.
Published: (2022) -
Liposome-Encapsulated Tobramycin and IDR-1018 Peptide Mediated Biofilm Disruption and Enhanced Antimicrobial Activity against <i>Pseudomonas aeruginosa</i>
by: Nouf M. Alzahrani, et al.
Published: (2022)